Percutaneous vertebroplasty in the surgical treatment of osteoporotic vertebral compression fractures: A retrospective study of 93 patients Authors: S. S. Etibarli, Rovshan S. Khalilzada, S A Etibarli, N P Ahmadov, Ibragimov Akobir, Bipin Chaurasia Published: 2026 ABSTRACT ABSTRACTBackground:Percutaneous vertebroplasty is a minimally invasive surgical technique used to stabilize and reinforce vertebral bodies affected by osteoporotic fractures, hemangiomas, primary spinal tumors, metastatic lesions, and other pathological conditions.Objective:The objective of this study is to evaluate the clinical effectiveness of percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures.Materials and Methods:This retrospective study analyzed the medical records of 93 patients who underwent surgical treatment for osteoporotic vertebral fractures between 2015 and 2024 at the Educational Surgery Clinic of Azerbaijan Medical University and Baku Health Center. The cohort included 73 women and 20 men. The mean age was 62.5 ± 1.1 years in women and 68 ± 2.3 years in men. All patients underwent clinical and neurological examination and the diagnosis was confirmed using spondylography, densitometry, computed tomography (CT), and magnetic resonance imaging. Percutaneous vertebroplasty was performed in 76 patients (81.7%). Cement augmentation was carried out at one vertebral level in 46 patients (60.5%), two levels in 25 patients (26%), four levels in 1 patient (1.3%), and five levels in 2 patients (2.6%).Results:Complete pain relief after surgery was observed in 93% of patients, while significant pain reduction occurred in 7%. Minor complications were reported in 5 patients (6.6%) and did not require additional surgical intervention.Conclusion:Percutaneous vertebroplasty is a safe, effective, and minimally invasive method for the surgical treatment of osteoporotic vertebral fractures. The procedure provides rapid pain relief, facilitates early restoration of mobility, and significantly reduces the need for analgesic medications. INTRODUCTION Osteoporotic vertebral compression fractures (OVCFs) represent a significant global health burden, particularly in the aging population, leading to pain, reduced mobility, and decreased quality of life.[12345678] Conservative treatment has traditionally been the first-line approach; however, it is often associated with prolonged immobilization and increased morbidity.[91011121314151617] Percutaneous vertebroplasty, first introduced by Deramond et al. in 1985, has emerged as a minimally invasive technique aimed at stabilizing vertebral fractures and providing rapid pain relief.[816] Since its introduction, vertebroplasty has been widely adopted for the treatment of osteoporotic fractures, vertebral hemangiomas, and metastatic lesions.[91011121314151617181920212223] However, despite its widespread use, the effectiveness of vertebroplasty remains controversial. Some randomized controlled trials and systematic reviews have questioned its superiority over conservative treatment,[56] while others have demonstrated significant clinical benefit, particularly in acute fractures.[210] Percutaneous vertebroplasty is indicated primarily for painful OVCFs refractory to conservative treatment, as well as for selected cases of vertebral tumors and hemangiomas. However, the procedure is not recommended in asymptomatic fractures, active spinal infections, or uncontrolled coagulopathy. Vertebroplasty was performed in France and USA since 1985, in Russia since 2000, and has been widely used in Azerbaijan since 2015. The aim of this study was to evaluate the clinical effectiveness of percutaneous vertebroplasty in patients with OVCFs. MATERIALS AND METHODS This retrospective, observational study analyzed the clinical outcomes of 93 patients with OVCFs treated between 2015 and 2024 at the Baku Health Center and the Educational Surgical Clinic of Azerbaijan Medical University. A total of 93 patients were included, comprising 73 females (78.5%) and 20 males (21.5%). The mean age was as follows: Females: 62.5 ± 1.1 years (range 39–86)Males: 68.5 ± 2.3 years (range 49–88). Females: 62.5 ± 1.1 years (range 39–86) Females: 62.5 ± 1.1 years (range 39–86) Males: 68.5 ± 2.3 years (range 49–88). Males: 68.5 ± 2.3 years (range 49–88). Inclusion criteria Symptomatic OVCFsPersistent pain refractory to conservative treatmentRadiological confirmation (X-ray, computed tomography [CT], and magnetic resonance imaging). Symptomatic OVCFs Symptomatic OVCFs Persistent pain refractory to conservative treatment Persistent pain refractory to conservative treatment Radiological confirmation (X-ray, computed tomography [CT], and magnetic resonance imaging). Radiological confirmation (X-ray, computed tomography [CT], and magnetic resonance imaging). Exclusion criteria Asymptomatic fracturesActive spinal infectionCoagulopathyKnown allergy to bone cement. Asymptomatic fractures Asymptomatic fractures Active spinal infection Active spinal infection Coagulopathy Coagulopathy Known allergy to bone cement. Known allergy to bone cement. All patients had been examined clinically and neurologically supplemented with two view spine radiography and CT and MR imaging. Patients were evaluated in 2 weeks using CT and radiographs and 1 year following the surgery. Percutaneous vertebroplasty was performed in 76 patients (81.7%). Distribution Single level: 46 patients (60.5%)Two levels: 25 patients (32.9%)≥4 levels: 3 patients. Single level: 46 patients (60.5%) Single level: 46 patients (60.5%) Two levels: 25 patients (32.9%) Two levels: 25 patients (32.9%) ≥4 levels: 3 patients. ≥4 levels: 3 patients. In 12 patients (12.9%) with epidural extension and dural sac compression, a combined surgical approach was performed, including decompressive laminectomy, open vertebral augmentation, and transpedicular fixation. In total, percutaneous vertebroplasty was performed on 116 vertebrae and open vertebroplasty was performed on 12 vertebrae, totaling 128 vertebrae in 58 patients. In cases where OVCFs extend into the epidural space and result in compression of the dural sac, a combined surgical approach was performed, including laminectomy, open vertebral body cement augmentation, and transpedicular fixation. This procedure was carried out in 12 patients (12.9%) in our series. The follow-up period was from 6 months to 10 years. Patients were evaluated by three criteria: the severity of the pain syndrome, the motor activity of the patients, and use of analgesics. The image intensifier has been used in all procedures. Technical details of the procedure All procedures were performed under fluoroscopic guidance using an image intensifier. Patients were positioned prone for thoracic and lumbar procedures. Vertebroplasty was performed: Unilaterally if vertebral height loss <50%Bilaterally if >50%. Unilaterally if vertebral height loss <50% Unilaterally if vertebral height loss <50% Bilaterally if >50%. Bilaterally if >50%. A 10G needle was used to perform vertebroplasty in the upper and mid-thoracic regions of the spine (Th5-Th8), and a 13G needle was used in the lower thoracic and lumbar vertebrae. A special syringe is used to inject cement into the vertebral body. Vertebroplasty usually involves two parts: Part I: Jamshidi needle insertion and Part II: cement injection. In part I, under local anesthesia, a special Jamshidi needle is inserted through the skin, subcutaneously and into the muscle. In the majority of patients (91%), vertebroplasty was performed under local anesthesia using 5% Marcaine. The advantage of local anesthesia is that it allows continuous verbal communication with the patient, enabling early detection and control of potential adverse effects of anesthesia. In addition, this approach makes it possible to perform vertebroplasty in patients with significant somatic comorbidities. In a smaller proportion of patients (9%), particularly those with severe acute pain or marked emotional agitation, vertebroplasty was performed under intravenous or endotracheal general anesthesia. For thoracic and lumbar vertebroplasty, prone position is utilized. The needle is further advanced through the pedicles (hence the procedure termed as percutaneous transpedicular vertebroplasty) and parked in the anterior 1/3 of the vertebral body. In the second part, polymethylmethacrylate (PMMA) cement is collected in a high-pressure syringe and slowly injected into the vertebral body. To monitor the filling of the vertebral body cavity with cement, a spiral CT scan is performed in the postoperative period. Depending on the route of Jamshidi needle to reach the body of the vertebrae, the following techniques are used: Anterolateral routeTranspedicular route [Figure 1]Posterolateral route. Anterolateral route Anterolateral route Transpedicular route [Figure 1] Transpedicular route [Figure 1] Posterolateral route. Posterolateral route. Transpedicular route Vertebroplasty with an anterolateral route is performed only on the cervical vertebrae. For this purpose, a thin 13G needle is used. The needle is directed to the vertebral body through the pectoralis major muscle in the plane between the vascular-nerve bundle laterally and the larynx-esophagus-thyroid gland medially. Under the control of the image intensifier, the needle is inserted into the vertebral body with light pressure. The distal end of the needle is advanced to the anterior 1/3 of the vertebral body. Transpedicular route is the most used one and it is performed on thoracic and lumbar spine. The needle is directed toward the root of vertebral pedicle which appears as an oval on the anteroposterior view of image intensifier scans. The needle is further advanced into the vertebral body and is parked in the anterior 1/3 of the latter [Figure 1]. We used this route in 85% of cases. In postero-lateral approach (also known as parapedicular route), the needle is inserted lateral to the root of vertebral pedicle. The optimal location of the needle is the area where the root of the vertebral pedicle joins the body and slightly distal to the lateral surface. This method is used in cases of gross compression fractures of the vertebral body and a sharp decrease in its height. It was applied in 15% of the cases. If extravertebral flow of cement is observed, the needle is removed immediately. Two to three milliliter of cement can be injected into the cervical vertebra, 5–8 ml into the thoracic vertebra, and 10 ml into the lumbar vertebra. Patients may take antibiotics for several days. Patients remained in a supine position for 15–20 min after the procedure. Control CT imaging was performed within 2–3 h postoperatively. Patients were discharged on the same day or within 24 h. Statistical analysis was performed using the standard descriptive and inferential methods. Continuous variables were expressed as mean ± standard deviation, whereas categorical variables were presented as frequencies and percentages. Normality of data distribution was assessed using the Shapiro–Wilk test. For normally distributed variables, paired Student’s t-test was used to compare the preoperative and postoperative values. In cases of nonnormal distribution, the Wilcoxon signed–rank test was applied. Changes in pain intensity were evaluated using estimated Visual Analog Scale (VAS) scores. Functional outcomes and analgesic use were analyzed using the categorical comparisons. The association between clinical improvement and procedural variables (number of treated vertebrae, cement volume, and surgical approach) was explored using Chi-square test or Fisher’s exact test where appropriate. P < 0.05 was considered statistically significant. All statistical analyses were performed using the SPSS software IBM (international Business Machines corporation) new orchard road, armonk, new york 10504-1722, United States. RESULTS Significant clinical improvement was observed following intervention. Complete pain relief was achieved in 71 patients (93.1%), while partial pain reduction was observed in 5 patients (6.6%). Functional outcomes improved substantially, with increased physical activity reported in 62 patients (82%). Discontinuation of analgesic medication was achieved in 69 patients (90.8%), while dose reduction was noted in the remaining cases. Pain intensity demonstrated a statistically significant reduction. Mean VAS score decreased from 8.0 ± 1.2 preoperatively to 2.5 ± 1.0 postoperatively (P < 0.001). Minor complications were observed in 5 patients (6.6%), presenting as transient postoperative pain exacerbation. These symptoms resolved within 1–2 days with conservative treatment using nonsteroidal anti-inflammatory drugs. No major complications, including neurological deterioration or need for revision surgery, were recorded. During the follow-up period (6 months to 10 years), clinical improvement was maintained in the majority of patients. Radiological evaluation demonstrated stable vertebral augmentation without evidence of progressive collapse at treated levels. Outcomes of patients treated with vertebroplasty for osteoporotic fractures are summarized in Table 1. Table 1Outcomes of patients treated with vertebroplasty for osteoporotic fracturesPainDependence on pain killersMotor activityComplicationsOsteoporptic fractureFull regression=93% 71 pts Decreased intensity=7% 6 pts Ineffective=-Full dsicontinuation=90.8% 69 pts Dose taper=9.2% 7 pts Ineffective=-Full recovery=82% 62 pts Partial recovery=18% 14 pts Ineffective=-6.6% 5 pts Outcomes of patients treated with vertebroplasty for osteoporotic fractures DISCUSSION The present study demonstrates that percutaneous vertebroplasty provides significant clinical benefits in patients with OVCFs, with a high rate of pain relief (93.1%), functional recovery (82%), and discontinuation of analgesic therapy (90.8%). These findings are consistent with the majority of observational studies and support the role of vertebroplasty as an effective minimally invasive intervention.[1715] One of the most important findings of this study is the rapid and substantial reduction in pain. The estimated decrease in pain intensity (VAS from approximately 8.0–2.5, P < 0.001) reflects immediate mechanical stabilization of the fractured vertebral body. This effect is believed to be related not only to structural reinforcement but also to thermal and chemical neurolysis caused by PMMA cement polymerization.[9] However, the role of vertebroplasty remains controversial. Randomized controlled trials, including the VAPOUR study, have reported mixed results, with some studies showing no significant difference compared to sham procedures.[56] In contrast, other studies have demonstrated clear clinical benefits, particularly in carefully selected patients.[210] The discrepancy between these findings may be explained by differences in patient selection, fracture age, and study design. In our study, patients were selected based on persistent severe pain and radiological confirmation, which likely contributed to the high success rate. Functional improvement is another important outcome. Early mobilization reduces the risk of complications associated with prolonged bed rest, including thromboembolic events and muscle atrophy, as reported in previous studies.[212223] The safety profile observed in our study is consistent with the literature. Minor complications were infrequent and did not require surgical intervention, which aligns with previously reported complication rates.[1112] From a technical perspective, the use of fluoroscopic guidance and careful control of cement viscosity are critical in minimizing complications. The predominance of transpedicular access in our series reflects current standard practice, ensuring optimal cement distribution and structural support. Importantly, our study reflects real-world clinical practice over a long observation period (up to 10 years), which strengthens the external validity of the findings. Unlike randomized trials with strict inclusion criteria, our cohort represents a broader patient population, making the results more applicable to everyday clinical settings. Nevertheless, several limitations must be acknowledged. First, the retrospective design introduces potential selection and reporting bias. Second, the absence of a control group limits the direct comparison with conservative treatment. Third, standardized outcome measures such as validated VAS or ODI scores were not systematically collected, although clinical outcomes were clearly documented. Future prospective, randomized studies with standardized outcome measures are necessary to further clarify the role of vertebroplasty and to identify patient subgroups that would benefit most from the procedure. CONCLUSION Percutaneous vertebroplasty demonstrated high clinical effectiveness in the treatment of OVCFs, providing rapid pain relief, early mobilization, and reduction in analgesic dependence. The procedure showed a favorable safety profile with a low rate of minor complications and no major neurological deterioration. Our findings support vertebroplasty as a valuable minimally invasive treatment option for carefully selected patients with symptomatic osteoporotic vertebral fractures. However, further prospective randomized studies with standardized outcome measures are required to better define long-term efficacy and optimal patient selection. Conflicts of interest There are no conflicts of interest.